QuantuMDx today announces a business update and the appointments of Jonathan O’Halloran as Chief Executive Officer and Neil Butler as Chairman of the Board, as the company begins its transition
Improving outcomes for sepsis patients and promoting antibiotic stewardship QuantuMDx and Ontera, have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection. The
Investigating feasibility of rapid, low-cost STI diagnostics development QuantuMDx and SpeeDx today announced a collaboration with the Foundation for Innovative New Diagnostics (FIND). The global non-profit organization drives development and
QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus
